This inactivation of the PI3K/Akt signaling pathway further downregulates prosurvival proteins, such as Bcl-xL, and results in apoptosis of T cells, thus sparing cancer cells from immune intervention [81]. The gene discussed is PIK3CA; the disease is cancer.